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We have determined the sequence of a venom allergen phospholipase A~ from white-faced hornet (Dolichovespula maculata) by cDNA and protein 
sequencings. This protein of 300 amino acid residues (Dol m I) has no sequence similarity with other known phospholipases. But it has sequence 
similarity with mammalian lipases; about 40% identity in overlaps of 123 residues. Tests suggest that hornet phospholipase has weak lipase activity. 
Hornet venom has 3 major allergens, and another hornet allergen antigen 5 (Dol m V) was previously found to have sequence similarity with a 
mammalian testis protein and a plant leaf protein. 
Hornet venom allergen; Phospholipase A~ 
1. INTRODUCTION 
One important group of insects which cause insect 
sting allergy of the immediate type is the vespids which 
include hornets, wasps and yellowjackets. The vespids 
have similar venom compositions, and their major 
venom allergens are hyaluronidase (43 kDa), phospho- 
lipase A~ (37 kDa) and antigen 5(23 kDa) which has as 
yet unknown biochemical function [1-3]. We have pre- 
viously determined the sequence of homologous antigen 
5s from white-faced hornet (Dolichovespula maculata) 
[4] and other wasps and yellowjackets [5]. Antigen 5 was 
found to have sequence similarities with pathogenesis- 
related proteins from tobacco and tomato leaves and a 
set of homologous proteins from human, rat and mouse 
testis; about 30% identity in overlaps of 130 residues 
[5,6]. According to the accepted allergen omenclature 
system [7], white-faced hornet phospholipase A~ and 
antigen 5 are designated Dol m I and Dol m V, respec- 
tively. 
Allergy of the immediate type is due to the presence 
of allergen-specific antibodies of IgE isotype. Antibody 
response to an immunogen/allergen d pends on the ge- 
netic make-up of the host, the route and mode of immu- 
nization/sensitization andthe nature of the immunogerd 
allergen. To what extent an allergen determines the out- 
come of IgE response is not known (cf. [8,9]). In our 
continuing effort to understand what immunochemical 
properties of a protein contribute to its allergenicity, we 
have cloned and sequenced the second major allergen 
of hornet venom. 
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2. MATERIALS AND METHODS 
2.1. Isolation and characterization f Dol m I and its CNBr peptides 
Dol m I was isolated from venom sac extracts of white-faced hornet 
(Vespa Laboratory, Spring Mills, PA) as described [3]. The protein 
(0.6 mg) was cleaved with CNBr (15 mg) in 75% HCO2H (0.2 ml) at 
25°C overnight. After cleavage the lyophilized mixture was separated 
on PepRPC column (Pharmacia, Piscataway, NJ) with a 2-propanol 
gradient of 0.1% per ml in 0.1% trifluoroacetic acid at a flow rate of 
40 ml per hour. Selected fractions were rechromatographed un er the 
same conditions after reduction and S-carboxymethylation [4].The 
recovered peptides were characterized by Edman degradation on an 
Applied Biosystems gas phase sequencer. 
2.2. Dol m I-specific DNA 
Total RNAs were isolated from the acid gland of white-faced hornet 
using the guanldine thiocyanate extraction procedure [4]. Dol m I- 
specific eDNA was obtained from total RNAs by the procedure of 
Frohman [10,11] for rapid amplification of 3' or 5' eDNA ends 
(RACE). 
First strand cDNAs were prepared using the MeHgOH (Invitrogen, 
San Diego, CA) denatured total RNAs (6 #g) as the template and 
other reagents of a eDNA synthesis kit from Gibco-BRL (Galthers- 
burg, MD) and RNasin (Promega Biotech) in a total reaction volume 
of 37/ll. For 5' RACE, the single strand cDNAs (from 6/ag of total 
RNAs) were poly-dA tailed with terminal deoxynucleotidyl trans- 
ferase (US Biochemical, Cleveland, OH). 3' or 5' RACE was carried 
out with GenAmp PCR reagent kit (Perkln-Elmer Cetus, Norwalk, 
CT) using AmpliTaq polymerase, and 3' RACE was also made with 
Vent polymerase (New England Biolabs, Bevery, MA). For first round 
PCR, 1/100 of the first strand cDNAs was used as a template. For the 
second round PCR, 1/1,000 of the first round PCR products was used 
as a template. 
PCR products were examined by electrophoresis in 1.5% agarose 
gel with ethidium bromide staining and by Southern blot analysis. 
DNA was transferred to nitrocellulose membrane (Schleicher & 
Schuell, Keene, NH) and then was immobilized by UV cross-linking. 
Membranes were soaked for 2 h at 42°C in a prehybridization solution 
of 30% formamide, 6 × SSPE [12], 5 x Denhardt's solution [12], 100 
/~g/ml salmon sperm DNA, 0.1% SDS then hybridized overnight at 
42°C with 3Zp-labeled ohgonucleotide probe (1 × 106 cpm per ml of 
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RLIMFVGDPSSSNELORFSY 3 
AGATTAATAATGTTCGTAGGTGATCCGTCGTCATCAAATG~TTAGATAGA~CTCCGTA 60 
CPFSNDTVYHIFLTRENRKH 
TGTCCCTTTAGTAATGATACAGTTAAGATGATTTTTTTAACAT 1:; 
D TLDTMNRHNEFKKSIIK 
GATT:TTr\TACGCTAGATACAATGAACAGGCACAATGAA 
43 
180 
C~TC~AGTTGTATTCATTACGC~TGGTTTTA~TTCGTCTGCAACCW\AAAAAATTTCGTT 
VVFIT GF SSATEKNFV 
2:; 3. RESULTS 
AHSEALMHTGDFLIIHVDWR 83 
GCTATGTCAGAGGCTCTTATGCATACAGGTGATTTTCTTAT~TTATGGTCGATTGGCGG 300 
MAAC DEY GLKYMFYKAAV 
ATGGCTGCTTGTA~TGATGAATACC~AGGTCTGAAGTATATGTTTTAT~GGCTGCCGTT 
GNTRLVGNFIAMIAKKLVEQ 123 
GGTAATACACGCTTAGTTGGAAATTTTATCGCTATGATCGCAAAGAAACTTGTAGAACAA 420 
YKVPMTNIRLVGHSLGAHIS 143 
TATAAAGTGCCGATGACAAATATACGACTGGTGGGACACAGTTTGGGCGCACACATTTCA 480 
GFAGKRVQELKLGKFSEU 163 
GGTTTCGCAGGCAAAAGAGTTCAAGAGTTAAAATTAGGAAAATTTTCTG~TTATTGGG 540 
L D G SFKKNDCSERICEI 
CTTGATC~TG~TGGGC~TAGTTTCAAGAAAAATGATTGTTCCGAGAGAATCTGCGAGACA 
DAHYVDILHTJSNLGTERTL 203 
GACGCACATTATGTACAAATTTTACATACATCGAGCAAiTCAGAGAGAACTCTT 660 
GTVDFYINNGSNQPGCRYII 223 
GGCACCGTCGATTTCTACATAAATAACGGAAGTAATCAACCCGGTTGCAGATATATTATT 720 
GETCSHTRAVKYFTECIRRE 243 
GGAGAAACTTGCTCTCATACGAGAGCCGTGAAATACTTTACCGAGTGCAT~GACGCG~ 780 
CCLIGVPQSKNPQPVSKCTR 263 
TGTTGTTTAATTGGGGTCCCGCAGTCCAAGAATCCGCAGCCTGTTTCG~GTGCAC~GA 840 
NECVCVGLNAKKYPKRGSFY 283 
AACGAGTGCGTTTGCGTTGGATTAAACGCAAAGAAATATCCTA~GGGGCTCATTTTAT 900 
VPVEAEAPYCNNNGKII+ 
GTACCGGTTGAAGCTGAAGCTCCATATTGCAATAACAACGGG~AT~~~TTATAT 
TTCAAGAAAAAAAAAAAAAAAAAAAAAAAA 
103 
360 
183 
600 
300 
960 
1020 
1050 
Fig. 1. cDNA and amino acid sequences of hornet phospholipase A, 
(Do/ m 1). Nucleotide and amino acid positions are numbered on the 
right. Numbering of amino acid residues begins and ends at its N- and 
C-termini of phenylalanine and tsoleucine, corresponding to nucleo- 
tide positions of 52-54 and 949995 1 and the ammo acid residues and 
nucleotides are shown m bold characters. The underlined amino acid 
residues were also established by Edman degradation of CNBr pep- 
tides. These sequence data are available from EMBLIGenbanWDDBJ 
under accession number X66869. 
prehybridization solution). Post hybridization membranes were twice 
washed for 20 min at 6O’C in a solution of 3 M tetramethylammonium 
chloride, 0.2% SDS and 0.05 M Tris-HCl, pH 8.0 [13]. Oligonu- 
cleotides of specific activity 5 x lo’-10’ cpm/pg were labeled with 
[y-32P]ATP (New England Nuclear Corp.) in presence of T4 polynu- 
cleotide kinase (New England Biolabs). The labeling procedure as well 
as other molecular biology procedures were taken from [12]. 
et6 
1 CONA synthesis 
5’ 
1 &I tailing 
PCR products contain single 3’-overhanging A-nucleotides [14] and 
were used directly for cloning into the pCR vector with compatible 
T-nucleotide overhangs (Invitrogen Corp., San Diego, CA). Plasmid 
DNAs were isolated from approprtate clones using the QIAGEN 
plasmid kit (QIAGEN, Chatworth, CA). DNA sequences were deter- 
mined by the dideoxynucleotide chain-termination method [15] using 
alkaline-denatured plasmid DNAs and the Sequenase version 2.0 kit 
(US Biochemical, Cleveland, OH). 
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2.3. Phosphohpase and lipase assays Fig. 2. Schematic diagram for rapid amplification of the 3’ and 5’ 
Phospholipase activity was measured titrimetrically at 24 + 1°C cDNA ends (RACE) of Do1 m I. Open and solid bars represent RNA 
and pH 8 in a volume of 1.5 ml with 0.2-2 pg of enzyme and 10% egg and DNA, respectively. The oligonucleotide primers are numbered, 
yolk as substrate m 0.2 N NaCl containmg 0.5% Triton [2]. One umt and their sequences are given in Table I. 
of activity is defined as the release of one pmol of acid per min per 
mg of enzyme. Lipase activity was measured similarly using either a 
2% solution of triacetin or a 2% emulsion of tributyrin (Sigma BIO- 
chemical, St. Louis, MO) as substrates in 0.2 N NaCl containing 0.5% 
Triton. 
3.1. Partial amino acid sequence of Do1 m I 
These data were obtained from its CNBr peptides. 
The partial or complete sequences of 7 of these peptides 
correspond to residues 1-12, 14-30, 32-57, 85-96, 98- 
112, 161-170, 183-194 and 244-251 of the molecule 
shown in Fig. 1. The first five peptides correspond to the 
expected cleavage as it is in each case either preceded or 
terminated with a methionine residue. The last three 
peptides represent side products from acid cleavage of 
glutamyl peptide bonds. These partial amino acid se- 
quence data were used for the design and synthesis of 
oligonucleotides 4 to 7 in Table I. 
A. 3' RACE 
+ #1 
1 cDNA synthesis 
- mJv$ 
#4+ + 12 
1 Put1 
(%R,R, 
mRIR0 
Ik + 13 
1 PCR 2 
(%PI 
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B. 5’ RACE 
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5' 
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3' 
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3.2. cDNA sequence of Do1 m Z 
cDNA encoding amino acid residues 22-300 and the 
3’-untranslated region was amplified from venom 
RNAs by the RACE procedure as outlined in Fig. 2A. 
Single stranded venom cDNAs were synthesized from 
total RNAs using a dT primer with R, + R, adaptor 
(oligonucleotide 1 in Table I). Double stranded Do1 m 
I-specific cDNA was amplified from single stranded 
venom cDNAs by two successive rounds of PCR using 
the nested primers as indicated. Several PCR products 
were detected and a major band of about 1 kb (Fig. 3) 
appeared to be the expected product when tested on 
Southern blot by hybridization with oligonucleotide 6 
(Table I). As shown in Fig. 3 the 1 kb band was only 
found when Taq polymerase was used and it was not 
found with Vent polymerase. 
The PCR products which contain the 1 kb band were 
cloned directly into plasmids. After transformation into 
bacteria, plasmids from 3 colonies were selected and 
sequenced. Two colonies have the nucleotide sequence 
of 115 to 1,050 in Fig. 1. One of them differs from that 
shown: by the deletion of one adenine base at position 
968, and by the insertion of an additional 99 nucleotides 
at position 1,027 (these data are not shown but are on 
deposit at EMBWGenbank). A third colony differs 
from that shown at position 807 (C to T substitution; 
both encoding serine) and at position 8 12 (A to G sub- 
stitution; asparagine to serine change). 
Using the cDNA data of Fig. 1, oligonucleotides 8 
and 9 in Table I were synthesized for amplifying the 
cDNA region which is 5’ of nucleotide 115 in Fig. 1. As 
shown in Fig. 2B, single stranded Do1 m I-specific 
cDNA was synthesized from total RNAs using oligonu- 
cleotide 6 as the primer then poly-dA tailed with termi- 
nal deoxynucleotidyl transferase. Double-stranded Do1 
m I-specific cDNA was amplified from poly-dA tailed 
specific cDNA by two successive rounds of PCR with 
the indicated primers. Several products formed after the 
second round of amplification and two bands of about 
0.32 and 0.25 kbp (Fig. 3) appeared to be the expected 
products when detected on Southern blot by hybridiza- 
tion with oligonucleotide 9 in Table I. Following clon- 
ing into a plasmid, the product of 0.32 kbp was estab- 
lished to contain the cDNA sequence from nucleotide 
1 to 262 in Fig. 1. 
The region preceding nucleotide position 52 in Fig. 
1 encodes a leader sequence of 17 amino acid residues 
as the N-terminal amino acid residue of DoZ m I was 
found on Edman degradation to begin at nucleotide 
position 52. The protein sequence suggests the presence 
of two possible glycosylation sites at residue 8 and 212. 
The site at residue 8 is probably glycosylated as re- 
Table I 
Oligonucleotides used as primers or probes for cloning hornet phospholipase 
No. Oligonucleotide* Comment 
AAG GAT CCGTCGACATCGATAATACGA 
CTCACT ATAGGGATT T,, 
AAGGATCCGTCGACATC 
GAC ATC GATAATACGAC 
D9T V K M II4 
GAYACI GTI AARATGAT 
K=H D F Y T*' 
AARCAY GAY TTY TAYAC 
1190 Q V Y H A D184 
AT YTG IAC RTARTG IGC RTC 
Pg2 Y E D T CB7 
GG RTAYTC RTC IGT RCA 
M"L A E Se6 
GCAT AAGAGC CTC TGAC 
M31T D L T27 
TCATTGTATC TAG CGTA 
(dTh7 R,R, primer for first strand cDNA synthesis of 3’ RACE 
R, anti-sense primer for first round PCR of 3’ RACE 
R, anti-sense primer for second round PCR of 3’ RACE 
Sense primer for first round PCR of 3’ RACE 
Sense primer for second round PCR of 3’ RACE 
Hybridization probe of PCR produce of 3’ RACE; or primer for 
first strand cDNA synthesis of 5’ RACE 
Anti-sense primer for first round PCR of 5’ RACE 
Anti-sense primer for second round PCR of 5’ RACE 
Hybridization probe for PCR product of 5’ RACE 
*R represents A or G, Y represents C or T, and I represents inosine. 
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A B 
12345 1234 
C D 
1.0 kb 
0.3 kb 
Fig. 3. 3’ and 5’ RACE of white-faced hornet phospholipase-specific 
cDNA. In panels (A) and (B) are shown, respectively, the agarose gel 
electrophoresis and Southern blot analysis products for 3’ RACE. In 
lanes 1 and 3 are shown the products from first and second round PCR 
obtained with AmpliTaq DNA polymerase, in lanes 2 and 4 are shown 
similar products obtained with Vent polymerase; and in lane 5 is 
shown a 1 kb DNA Ladder (BRL). In panels (C) and (D) are shown 
similar results (as in panels (A) and (B)) for 5’ RACE products (lane 
1) obtained with AmpliTaq DNA polymerase; and in lane 2 (panel (C)) 
is shown 1 kb DNA Ladder. The arrows in panels (B) and (D) indicate 
the desired products. The hybridization probes are given in Table I. 
peated attempts to identify this residue by Edman deg- 
radation gave negative results. This is also suggested by 
the difference in the molecular weight of 33,745 calcu- 
lated from the sequence and that of about 37,000 esti- 
mated from SDS gel electrophoresis. 
3.3, Lipase activity of hornet phosphohpase 
We reported previously [3] that vespid phospholi- 
pases catalyze a rapid hydrolysis of the acyl group at 
position 1 of synthetic phosphatidylcholines and a slow 
hydrolysis of the acyl group at position 2. Therefore 
vespid phospholipases have both A, and B types of 
phospholipase activities. The present finding on se- 
quence similarity of hornet phospholipase with lipases 
prompted us to test for lipase activity. 
The enzyme sample tested had about 280 units of 
phospholipase activity per mg when tested with egg yolk 
as a substrate as compared to the previously reported 
specific activity of 1,100 units per mg [3], and its low 
specific activity was due to inadvertent prolonged expo- 
sure to low pH. This sample had the following lipase 
activities of 13 and 33 (? 20%) units/mg with triacetin 
and tributyrin, respectively, as substrates. These data 
suggest hornet phospholipase has a weak lipase activity. 
4. DISCUSSION 
Sequence comparison by the FASTA method [l l] 
showed that hornet phospholipase Do1 m I has no sim- 
ilarity with other known phospholipases in the litera- 
ture, but it has similarity with mammalian lipases. This 
is shown in Fig. 4 for lipoprotein lipases and hepatic 
lipases from human and mouse [16&l 91. Human pancre- 
atic lipase 1201 has about the same degree of similarity 
with Do1 m I as human hepatic lipase (data not shown). 
148 
There is about 40% identity in overlaps of 123 residues 
of mammalian lipases and Do1 m I. The sequence region 
of lipases shown in Fig. 4 is highly conserved as similar 
sequences are found for a number of other mammalian 
and prokaryotic lipases and a Drosophila protein vitel- 
logenin [2 1,221. Thus these proteins also have significant 
sequence similarity with Dol m I. 
The most strongly conserved region of all lipases is 
reported to be in the undecapeptide region of residue 
153-163 of human lipoprotein lipase [21]. This region 
is believed to be of importance for lipase activity, and 
it is the region of highest identity of lipases and Do1 m 
I. Tests with two synthetic triglycerides suggest the pres- 
ence of a weak lipase activity for Do1 m I. 
All vespid allergic patients invariably have antibodies 
specific for both Do1 m I and V. Therefore we compared 
the sequences of these two proteins and they are found 
to share one similar octapeptide sequence; 
VNRHNQFR and LKRHNDFR at position 45-52 of 
Do1 m VA and B, respectively, and MNRHNEFK at 
position 31-38 of Do1 m I. However this octapeptide 
sequence is not in the sequence region where these aller- 
gens show similarity with other proteins. 
There are several examples of sequence similarity of 
allergens with other proteins in our environment. They 
are birch pollen allergen Bet v I with a pea disease 
resistance response protein gene [23], another birch pol- 
len allergen and its homologs from timothy and 
mugwort pollens with human profilin [24], ragweed pol- 
len allergens Amb a I and II with proteins from tomato 
anther and pistil (cf. [25]), cat allergen Fe1 d I with rabbit 
uteroglobin [26], mite allergen Der p I with human 
cathepsin and other cysteine proteases [27], bee venom 
allergen phospholipase A, with human pancreatic en- 
zyme and bee venom allergen melittin Api m III with 
Hu LPL YPVSAGYTKLVGQDVARFINWMEEEFNYPLDNVHLLGYSLGAHAAGIAG 169 
MO LPL YPVSAGYTKLVGNDVARFINWMEEEFNYPLDNVHLLGYSLGAHAAGVAG 161 
Hu HL YTIAVRNTRLVGKEVAALLRWLEESVQLSRSHVHLIGYSLGAHVSGFAG 178 
MO HL YTQASYNTRVLGAEIAFLVQVLSTEMGYSPENVHLIPHSLGSHVAGEAG 180 
Dm PLA YKAAVGNTRLVGNFIAMIAKKLVEPYKVPMTNIRLVGHSLGAHISGFAGK 148 
P+L Y GTLVG A P N L G SLGAH G AG 
P+H Y AV NTRLVG A L G SLGAH SGFAG 
Hu LPL SLTNKKVNRITGLDPAGPNFEYAEAPSRLSPDDADFVDVLHT FTRG 215 
MO LPL SLTNKKVNRITGLDPAGPNFEYAEAPSRLSPDDADFVDVLHT FTRG 207 
Hu HL SSIGGTHKIGRITGLDAAGPLFEGSAPSNRLSPDDANFVDAIHT FTRE 226 
MO HL RRLEGHVGRITGLDPAEPCFQGLPEEVRLDPSDAMFVDVIHTDSAPI 227 
Dm PLA RVQELKLGKFSEIIGLDPAGPSFKKNDCSERICETDAHYVQILHT 193 
P+L K I GLDPAGP F R DA V LHT 
P+H K I GLD AGP F S R DA V HT 
Hu LPL SPGRSIGIOKPVGHVDIYPNGGTFOPGC 243 
MO LPL 
Hu HL 
MO HL 
Dm PLA 
P+L 
P+H 
SPGRSIGIIjKPVGHVDIYPNGGTFdPGC 235 
HMGLSVGIKQPIGHYDFYPNGGSFQPGC :s4 
IPYLGFGMSQKVGHLDFFPNGGKEIPGC 255 
SSNLGTERTLGTVDFYINNGSNQPGC 219 
G VD Y N G QPGC 
G DFY N GS QPGC 
Fig. 4. Sequence similarity of Do1 m I and mammalian lipases. Amino 
acid positions are numbered on the right. Abbreviations used: Hu. 
human: MO, mouse; LPL, lipoprotein lipase; HL, hepatlc lipase; Dm. 
white face hornet; and PLA, phospholipase. P + L and P + H indicate 
residues of hornet phospholipase which are identical to human lipo- 
protein or hepatic lipases. respectively. 
Volume 320, number 2 FEBS LETTERS April 1993 
human complement  C9 (cf. [6]). However several other 
major  allergens from mite [28] and ragweed and grass 
pol lens [29-31] have no known sequence similarity with 
other proteins in our environment.  
The accumulated sequence data makes it possible to 
analyze whether the T and/or  B cell epitope of  these 
allergens are located in the regions of  sequence similar- 
ity with other proteins in our  environment.  Such analy- 
sis will provide the necessary proo f  whether sequence 
similarity plays a role in the immunogenic i ty of  aller- 
gens in man. 
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